Optimed Immunology prescribes the full range of FDA-approved therapies for the conditions treated. Treatment is individualized to each patient's diagnosis, lifestyle, and goals. Each medication below links to a detailed reference page.
Before the catalog
The medication list below is comprehensive, but treatment selection is not a menu. Each decision starts with diagnosis, then proceeds through severity, prior response, comorbidities, and what the insurance carrier requires for authorization. These are the five lenses Dr. McNeil uses when building a treatment plan.
When the immune system cannot make enough functional antibody — IVIG, SCIG, or facilitated SCIG.
For HAE and other episodic conditions, distinguishing daily prevention from on-demand rescue.
When asthma, hives, nasal polyps, eczema, or EoE are driven by allergic or eosinophilic biology.
Some conditions need diagnostic clarification before any advanced therapy is appropriate.
Objective labs, prior failures, severity, and comorbidities all support prior authorization — which the office handles in-house.
For patients with primary antibody deficiencies. Administered every 3–4 weeks at home, in our suite, or at a partner infusion center.
immune globulin (human) · Takeda
Primary humoral immunodeficiency (PI).
Learn more →immune globulin intravenous (human) 10% liquid · CSL Behring
Primary humoral immunodeficiency.
Learn more →immune globulin intravenous (human) 10% / 5% · Octapharma USA
Primary humoral immunodeficiency.
Learn more →immune globulin intravenous (human) 10% liquid · Octapharma USA
Primary humoral immunodeficiency.
Learn more →immune globulin intravenous (human) 10% liquid · ADMA Biologics
Primary humoral immunodeficiency in adults and adolescents.
Learn more →immune globulin intravenous (human) 10% liquid · ADMA Biologics
Primary humoral immunodeficiency.
Learn more →immune globulin intravenous, human-stwk 10% liquid · GC Biopharma
Primary humoral immunodeficiency in adults.
Learn more →immune globulin intravenous, human 5% / 10% liquid · Bio Products Laboratory / Kedrion
Primary humoral immunodeficiency.
Learn more →immune globulin injection (human) 10% · Grifols
Primary humoral immunodeficiency.
Learn more →Self-administered weekly or biweekly at home, with HyQvia offering monthly large-volume facilitated subcutaneous dosing.
immune globulin subcutaneous (human) 20% liquid · CSL Behring
Primary humoral immunodeficiency.
Learn more →immune globulin subcutaneous (human) 20% solution · Takeda
Primary humoral immunodeficiency.
Learn more →immune globulin subcutaneous (human)-klhw 20% · Grifols
Primary humoral immunodeficiency.
Learn more →immune globulin subcutaneous (human)-hipp 16.5% · Octapharma USA
Primary humoral immunodeficiency.
Learn more →immune globulin infusion 10% (human) with recombinant human hyaluronidase · Takeda
Primary humoral immunodeficiency.
Learn more →Daily, weekly, monthly, or less frequent treatments to prevent HAE attacks before they happen.
lanadelumab-flyo · Takeda
Prevention of HAE attacks in patients ≥2 years.
Learn more →C1 esterase inhibitor subcutaneous (human) · CSL Behring
Routine prophylaxis to prevent HAE attacks in adolescent and adult patients.
Learn more →C1 esterase inhibitor (human) · Takeda
Routine prophylaxis against HAE attacks in adult and pediatric patients.
Learn more →berotralstat · BioCryst Pharmaceuticals
Prophylaxis to prevent HAE attacks in adults and pediatric patients ≥12.
Learn more →garadacimab-gxii · CSL Behring
Routine prophylaxis to prevent HAE attacks in adults and pediatric patients ≥12 years.
Learn more →donidalorsen · Ionis Pharmaceuticals
Routine prophylaxis to prevent HAE attacks in patients ≥12 years.
Learn more →Rescue medications for acute HAE attacks. Options include intravenous, subcutaneous, and now oral therapies. Most support patient self-administration at home.
C1 esterase inhibitor (human) · CSL Behring
Treatment of acute abdominal, facial, or laryngeal HAE attacks.
Learn more →icatibant · Takeda
Treatment of acute attacks of HAE in adults.
Learn more →C1 esterase inhibitor [recombinant] · Pharming Healthcare
Treatment of acute HAE attacks in adult and adolescent patients.
Learn more →ecallantide · Takeda
Treatment of acute HAE attacks in patients ≥12 years.
Learn more →sebetralstat · KalVista Pharmaceuticals
Treatment of acute HAE attacks in adult and pediatric patients ≥12 years.
Learn more →Targeted therapies for severe asthma, chronic urticaria, nasal polyps, atopic dermatitis, and EoE. Selection is based on phenotype, comorbidities, and dosing preference.
omalizumab · Genentech / Novartis
Moderate to severe persistent allergic asthma.
Learn more →mepolizumab · GlaxoSmithKline (GSK)
Severe eosinophilic asthma.
Learn more →reslizumab · Teva Pharmaceuticals
Severe eosinophilic asthma in adults.
Learn more →depemokimab-ulaa · GlaxoSmithKline (GSK)
Add-on maintenance treatment of severe asthma with eosinophilic phenotype in patients ≥12 years.
Learn more →benralizumab · AstraZeneca
Severe eosinophilic asthma.
Learn more →dupilumab · Sanofi / Regeneron
Moderate to severe atopic dermatitis.
Learn more →tezepelumab-ekko · AstraZeneca / Amgen
Severe asthma in patients ≥12 years (broad eligibility regardless of phenotype).
Learn more →Targeted therapies for selected innate immune disorders, including periodic fever syndromes, when diagnostic criteria and insurance requirements are met.
Inhaled and nebulized therapies are selected based on asthma severity, exacerbation history, lung function, biomarkers, and response to prior treatment.
Emergency medications for patients at risk of severe allergic reactions. Patients should follow their individualized emergency action plan and seek emergency care when appropriate.
Standard and advanced immune testing performed in support of diagnosis and treatment monitoring.
SIP · In-house
Rapid screening of immune disorders and monitoring of immunodeficiency.
CPA · In-house
Evaluates immune cell function in post-COVID and persistent post-viral immune dysregulation.
BAT · In-house
Measures basophil response to allergen stimulation. Used in food allergy management.
Pre/post-vaccination titers
Assesses specific antibody response. Key for diagnosing specific antibody deficiency.
Specific IgE panels
Comprehensive allergy testing without scratch tests.